Midjourney Medical has unveiled plans for its Midjourney Scanner, a full-body ultrasound imaging device powered by 40 Butterfly Network ultrasound-on-chip imaging modules.
The scanner uses a water-immersion design in which a patient descends on a platform through a ring of ultrasonic sensors, with a target scan time of 60 seconds. The sensors send ultrasonic waves through the body from multiple angles, with the resulting data processed to produce 3D images of internal anatomy down to a fraction of a millimeter, the company said. Midjourney said the image quality is comparable to MRI but at significantly faster acquisition speeds.
Example image from the Midjourney Scanner. Each slice continuously crossfades between the raw reconstruction and its AI segmentation.Midjourney
Butterfly's imaging modules incorporate approximately 500,000 sensors and more than two petaflops of processing power.
The device is not yet cleared by the U.S. Food and Drug Administration (FDA), but Midjourney said it plans to submit regular test results to the FDA as it develops diagnostic capabilities. The company also said it currently intends to offer body composition mapping as an initial use case. It plans to open its first scanner location, integrated into a spa facility in San Francisco, in 2027.
The collaboration with Butterfly Network is enabled through Butterfly's Embedded co-development program, and Butterfly previously disclosed up to $74 million in expected payments over a five-year term in a November 2025 filing with the U.S. Securities and Exchange Commission (SEC). Midjourney said its longer-term goal is to deploy more than 50,000 scanners worldwide by 2031.
